94 related articles for article (PubMed ID: 29419277)
1. Acute Graft-versus-Host Disease.
Rezvani AR
N Engl J Med; 2018 Feb; 378(6):585-586. PubMed ID: 29419277
[No Abstract] [Full Text] [Related]
2. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
[TBL] [Abstract][Full Text] [Related]
3. Graft-versus-host disease.
Parkman R
Annu Rev Med; 1991; 42():189-97. PubMed ID: 2035965
[TBL] [Abstract][Full Text] [Related]
4. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
[TBL] [Abstract][Full Text] [Related]
5. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
6. Human graft-versus-host disease.
Parkman R
Immunodefic Rev; 1991; 2(4):253-64. PubMed ID: 2059433
[TBL] [Abstract][Full Text] [Related]
7. [Monitoring lymphocyte activity in the peripheral blood of patients after bone marrow transplantation].
Hrabánek J; Lukásová M; Chudomel V; Smetana K
Cas Lek Cesk; 1994 Jan; 133(3):80-2. PubMed ID: 8137377
[TBL] [Abstract][Full Text] [Related]
8. Acute graft-versus-host disease in allogeneic marrow transplantation.
Parker N; Cohen T
Nurs Clin North Am; 1983 Sep; 18(3):569-77. PubMed ID: 6351023
[No Abstract] [Full Text] [Related]
9. The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation.
Terdiman JP; Linker CA; Ries CA; Damon LE; Rugo HS; Ostroff JW
Endoscopy; 1996 Oct; 28(8):680-5. PubMed ID: 8934085
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of acute graft-versus-host disease.
Dignan FL; Clark A; Amrolia P; Cornish J; Jackson G; Mahendra P; Scarisbrick JJ; Taylor PC; Hadzic N; Shaw BE; Potter MN; ;
Br J Haematol; 2012 Jul; 158(1):30-45. PubMed ID: 22533831
[TBL] [Abstract][Full Text] [Related]
12. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K
Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
[TBL] [Abstract][Full Text] [Related]
13. CT features with pathologic correlation of acute gastrointestinal graft-versus-host disease after bone marrow transplantation in adults.
Kalantari BN; Mortelé KJ; Cantisani V; Ondategui S; Glickman JN; Gogate A; Ros PR; Silverman SG
AJR Am J Roentgenol; 2003 Dec; 181(6):1621-5. PubMed ID: 14627585
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.
Truog AW; Wozniak SP
Oncol Nurs Forum; 1990; 17(1):39-44. PubMed ID: 2405360
[TBL] [Abstract][Full Text] [Related]
15. Objective monitoring of graft-versus-host disease: alpha 1-antichymotrypsin concentration changes after bone marrow transplantation in patients developing graft-versus-host reactions.
Kamiguchi H; Ohkubo T; Yamamura M; Katsunuma T
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):165-8. PubMed ID: 3914740
[TBL] [Abstract][Full Text] [Related]
16. [Effect of bone marrow mesenchymal stem cells on acute graft versus host disease and graft versus leukemia after allogeneic bone marrow transplantation].
Hu WB; Gao QP; Chen YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):404-7. PubMed ID: 15972130
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Champlin R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
[No Abstract] [Full Text] [Related]
18. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
Clerici M; Villa ML; Clerici E
Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
Baumeister RG; Riel KA; Kolb HJ
Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
[TBL] [Abstract][Full Text] [Related]
20. Changes of cytokines during the course of graft-versus-host disease following bone marrow transplantation: a case report.
Takatsuka H; Takemoto Y; Okada M; Sawada A; Katsuno T; Wada H; Kakishita E
Cytokine; 2000 Aug; 12(8):1225-7. PubMed ID: 10930300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
